San Juan Capistrano, CA, United States of America

Vicken H Karageozian

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 3.7

ph-index = 9

Forward Citations = 323(Granted Patents)


Location History:

  • Laguna Beach, CA (US) (2011 - 2014)
  • San Juan Capistrano, CA (US) (1996 - 2023)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Vicken H Karageozian: Innovator in Peptide Therapies

Introduction

Vicken H Karageozian is a prominent inventor based in San Juan Capistrano, California. He has made significant contributions to the field of peptide therapies, particularly in the treatment of diseases associated with oxidative stress. With a total of 14 patents to his name, his work has the potential to impact various medical conditions.

Latest Patents

Karageozian's latest patents focus on innovative treatments for diseases and disorders that involve oxidative stress. One notable patent involves peptide compounds that are used in treating conditions characterized by cellular oxidative stress. Another significant patent addresses peptide therapies aimed at reducing macular thickening. This includes compounds comprising R-G-Cysteic Acid and its derivatives, which have applications in inhibiting integrins and preventing or treating viral infections, among other therapeutic uses.

Career Highlights

Throughout his career, Vicken H Karageozian has worked with notable companies such as Ista Pharmaceuticals, Inc. and Advanced Corneal Systems. His experience in these organizations has contributed to his expertise in developing cutting-edge therapies that address critical health issues.

Collaborations

Karageozian has collaborated with several professionals in his field, including Hampar L Karageozian and John Y Park. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in peptide therapies.

Conclusion

Vicken H Karageozian stands out as a key figure in the development of peptide therapies for oxidative stress-related diseases. His extensive patent portfolio and collaborative efforts underscore his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…